1. Market Research
  2. > Pathology Industry

Ovarian Cancer Industry, April 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Pharmaceutical, Antigen, Cancer Drug, Therapeutics, Biomarker, Cancer Diagnostic, Molecular Diagnostic, Surgery.


 
1-10 of 43 reports for Ovarian Cancer

Purchase Reports From Reputable Market Research Publishers

Ovarian Cancer Treatment Drugs Companies in China

Ovarian Cancer Treatment Drugs Companies in China

  • $ 1 800
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Ovarian Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions ...

Global Ovarian Cancer Partnering 2010 to 2016

Global Ovarian Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • April 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Ovarian Cancer Treatment Drugs Industry Forecasts - China Focus

Ovarian Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Ovarian Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing ...

Ovarian Cancer Treatment Drugs Markets in China

Ovarian Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Ovarian Cancer Drug Pipeline Update

Ovarian Cancer Drug Pipeline Update

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

Ovarian Cancer Drug Pathway Analyzer

Ovarian Cancer Drug Pathway Analyzer

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 427 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

Target Atlas in Ovarian Cancer: A Competitive Outlook

Target Atlas in Ovarian Cancer: A Competitive Outlook

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Ovarian Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in ovarian ...

 Metastatic Ovarian Cancer-Pipeline Insights, 2016

Metastatic Ovarian Cancer-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Metastatic Ovarian Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Ovarian ...

 Epithelial Ovarian Cancer-Pipeline Insights, 2016

Epithelial Ovarian Cancer-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Epithelial Ovarian Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Epithelial Ovarian ...

Middle East & Africa Ovarian Cancer Diagnostics and therapeutics market - segmented by type of cancer and geography (2015-2020)

Middle East & Africa Ovarian Cancer Diagnostics and therapeutics market - segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

The Middle East & African market for ovarian cancer diagnostics and therapeutics accounted for USD 33 million in 2015 and is anticipated to grow at a CAGR of 10-16% by 2020. Ovarian cancer is caused by ...

About 1 900 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2015
    97 pages
  • Cancer  

  • United States  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.